Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses

Nature Medicine

Volumn 6, Issue 3, 2000, Pages 327-331

  Ohashi, Kazuo ^a   Marion, Patricia L ^a   Nakai, Hikoyuki ^a   Meuse, Leonard ^a   Cullen, John M ^b   Bordier, Bruno B ^a   Schwali, Ralph ^c   Greenberg, Harry B ^a   Glenn, Jeffrey S ^a   Kay, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; DELTA AGENT HEPATITIS; DNA DETERMINATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; LIFE CYCLE; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS PATHOGENESIS;

ANIMALS; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; LIVER; MICE; MICE, INBRED NOD; MICE, SCID; PROTO-ONCOGENE PROTEINS C-MET; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; DELTA VIRUS; DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; MUS MUSCULUS; RODENTIA;

EID: 0034018854     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/73187     Document Type: Article

References (25)

1. Fox, I.J. et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338, 1422-1426 (1998).
2. Gupta, S., Rajvanshi, P. & Lee, C.D. Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats. Proc. Natl. Acad. Sci. USA 92, 5860-5864 (1995).
3. Overturf, K. et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nature Genet. 12, 266-273 (1996).
4. Ponder, K. et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl. Acad. Sci. USA 88, 1217-1221 (1991).
5. Rhim, J.A., Sandgren, E.P., Degen, J.L., Palmiter, R.D., & Brinster, R.L. Replacement of diseased mouse liver by hepatic cell transplantation. Science 263, 1149-1152 (1994).
6. Sandgren, E.P. et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66, 245-256 (1991).
7. Vrancken Peeters, M.T.F.D., Patijn, G.A., Lieber, A., Perkins, J. & Kay, M.A. Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice. Hepatology 25, 884-888 (1997).
8. Petersen, J., Dandri, M., Gupta, S., & Rogler, C.E. Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 95, 310-315 (1998).
9. Araki, K. et al. Expression and replication of hepatitis B virus genome in transgenic mice. Proc. Natl. Acad. Sci. USA 86, 207-211 (1989).
10. Guidotti, L.G., Matzke, B., Schaller, H., Chisari, F.V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158-6169 (1995).
11. Casey, J.L. Hepatitis delta virus. Genetics and pathogenesis. Clin. Lab. Med. 16, 451-464 (1996).
12. Lai, M.M. The molecular biology of hepatitis delta virus. Annu. Rev. Biochem. 64, 259-286 (1995).
13. Lau, D.T. et al. Lamivudine for chronic delta hepatitis. Hepatotogy 30, 546-549 (1999).
14. Michalopoulos, G.K. & DeFrances, M.C. Liver regeneration. Science 276, 60-66 (1997).
15. Ray, M.B. in Hepatitis B virus antigens in tissues 69-76 (Univeristy Park Press, Baltimore, Maryland, 1979).
16. Netter, H.J., Kajino, K. & Taylor, J.M. Experimental transmission of human hepatitis delta virus to the laboratory mouse. J. Virol. 67, 3357-3362 (1993).
17. Verme, G. et al. A histological study of hepatitis delta virus liver disease. Hepalology 6, 1303-1307 (1986).
18. Ilan, E. et al., The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 29, 553-562 (1999).
19. Glenn, J.S. Shutting the door on hepatitis delta virus (HDV): Sensitivity to prenylation inhibition prompts new therapeutic strategy. Virol Hepatitis Rev. 5, 13-26 (1999).
20. Lieber, A. et al. Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J. Virol. 70, 8782-8791 (1996).
21. Sells, M.A., Chen, M.L. & Acs, G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84, 1005-1009 (1987).
22. Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P. & Charnay, P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281, 646-650 (1979).
23. Glenn, J.S., Watson, J.A., Havel, C.M. & White, J.M. Identification of a prenylation site in delta virus large antigen. Science 256, 1331-1333 (1992).
24. Erhardt, A. et al., Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence. J. Clin. Microbiol. 34, 1885-1891 (1996).
25. Wang, K.S. et al. Structure, sequence an expression of the hepatitis delta viral genome. Nature 323, 508-514 (1986).